Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.
Savonitto S, Cavallini C, Petronio AS, Murena E, Antonicelli R, Sacco A, Steffenino G, Bonechi F, Mossuti E, Manari A, Tolaro S, Toso A, Daniotti A, Piscione F, Morici N, Cesana BM, Jori MC, De Servi S; Italian Elderly ACS Trial Investigators. Savonitto S, et al. Among authors: toso a. JACC Cardiovasc Interv. 2012 Sep;5(9):906-16. doi: 10.1016/j.jcin.2012.06.008. JACC Cardiovasc Interv. 2012. PMID: 22995877 Free article. Clinical Trial.
Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study.
Leoncini M, Toso A, Maioli M, Bellandi F, Badia T, Politi A, De Servi S, Dabizzi RP. Leoncini M, et al. Among authors: toso a. Am Heart J. 2005 Sep;150(3):401. doi: 10.1016/j.ahj.2005.06.006. Am Heart J. 2005. PMID: 16169315 Clinical Trial.
High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
Leoncini M, Toso A, Maioli M, Angiolillo DJ, Giusti B, Marcucci R, Abbate R, Bellandi F. Leoncini M, et al. Among authors: toso a. JACC Cardiovasc Interv. 2013 Feb;6(2):169-79. doi: 10.1016/j.jcin.2012.09.013. JACC Cardiovasc Interv. 2013. PMID: 23428009 Free article. Clinical Trial.
Renal function estimation and one-year mortality in elderly patients with non-ST-segment elevation acute coronary syndromes.
Morici N, De Servi S, Toso A, Murena E, Tamburrini P, Antonicelli R, del Pinto M, Cavallini C, Petronio AS, Giannini C, Piscione F, Bolognese L, Savonitto S. Morici N, et al. Among authors: toso a. Int J Cardiol. 2014 Jun 1;174(1):127-8. doi: 10.1016/j.ijcard.2013.12.306. Epub 2014 Jan 10. Int J Cardiol. 2014. PMID: 24447752 No abstract available.
One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: effect of diabetic status and admission hyperglycemia.
Savonitto S, Morici N, Cavallini C, Antonicelli R, Petronio AS, Murena E, Olivari Z, Steffenino G, Bonechi F, Mafrici A, Toso A, Piscione F, Bolognese L, De Servi S. Savonitto S, et al. Among authors: toso a. J Am Geriatr Soc. 2014 Jul;62(7):1297-303. doi: 10.1111/jgs.12900. Epub 2014 Jun 10. J Am Geriatr Soc. 2014. PMID: 24917216
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
Palmerini T, Calabrò P, Piscione F, De Servi S, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Mariani A, Taglieri N, Reggiani LB, Bianchi R, De Rosa R, Mariani M, Podda G, Généreux P, Stone GW, Angiolillo DJ. Palmerini T, et al. Among authors: toso a. JACC Cardiovasc Interv. 2014 Oct;7(10):1117-27. doi: 10.1016/j.jcin.2014.04.020. Epub 2014 Sep 17. JACC Cardiovasc Interv. 2014. PMID: 25240538 Free article.
Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome.
Morici N, De Servi S, Toso A, Murena E, Piscione F, Bolognese L, Petronio AS, Antonicelli R, Cavallini C, Angeli F, Savonitto S. Morici N, et al. Among authors: toso a. Eur Heart J Acute Cardiovasc Care. 2015 Oct;4(5):453-60. doi: 10.1177/2048872614557221. Epub 2014 Oct 27. Eur Heart J Acute Cardiovasc Care. 2015. PMID: 25348274 Clinical Trial.
Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
Toso A, Leoncini M, Maioli M, Tropeano F, Di Vincenzo E, Villani S, Bellandi F. Toso A, et al. JACC Cardiovasc Interv. 2014 Dec;7(12):1421-9. doi: 10.1016/j.jcin.2014.06.023. JACC Cardiovasc Interv. 2014. PMID: 25523533 Free article. Clinical Trial.
173 results